Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-054453)

Filing Details

Accession Number:: 0001104659-15-054453
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-07-29 18:19:30
Reporting Period:: 2015-07-13

Filing Date:: 2015-07-29
Accepted Time:: 2015-07-29 18:19:30
Original Submission Date:: 2015-07-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356576	Supernus Pharmaceuticals Inc	SUPN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557657	K.f. Stefan Schwabe	C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850	Executive Vice President R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-07-13	1,950	$19.23	2,350	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.
The Reporting Person is amending the Form 4 filed on July 14, 2015 to reflect the fact that the number of securities owned after the reported transaction includes an aggregate of 1,506 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.